Abstract
The literature is limited on ViV TAVR in stentless vs. stented bioprosthetic surgical aortic valve. We retrospectively analyzed 36 patients who underwent ViV TAVR in prior surgical bioprosthetic valves at Wake Forest Baptist Medical Center from October 2014 to December 2016. 28/36 (77.8%) ViV TAVR
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
